Rare diseases
Investigational molecules
Locations
Back to Italy1 clinical trial in Termoli, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)ItalyThe busiest research cities in the country
What the registry says about research in the country
Investigating optimal treatment timing for endocrine-responsive breast cancer patients, focusing on the integration of chemotherapy and hormone therapy approaches.
This research addresses a critical need in breast cancer treatment, specifically examining sequential versus concurrent administration of aromatase inhibitors and chemotherapy in post-menopausal women.
Clinical research focusing on hormone-responsive tumors, which represent approximately 80% of breast cancer cases in North America, Europe, and Latin America.
The study aims to determine the most effective timing strategy for combining different treatment modalities in early-stage breast cancer patients.
Comprehensive evaluation of adjuvant treatment approaches for post-menopausal patients with early-stage breast cancer.
This research explores the impact of treatment timing on patient outcomes, focusing on preventing disease recurrence through optimized therapeutic combinations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
